Increased arterial stiffness in mildly-hypertensive women with polycystic ovary syndrome

Journal of Obstetrics and Gynaecology Research

Volumn 37, Issue 5, 2011, Pages 402-411

  Sasaki, Aiko ^a,c   Emi, Yayoi ^b   Matsuda, Miwa ^a,c   Sharula, ^a,c   Kamada, Yasuhiko ^c   Chekir, Chebib ^c   Hiramatsu, Yuji ^a,c   Nakatsuka, Mikiya ^b,c  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c OKAYAMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Augmentation index; Blood pressure; C reactive protein; Polycystic ovary syndrome; Pulse wave velocity

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; FATTY ACID; FOLLITROPIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID; PROLACTIN; TESTOSTERONE;

ADULT; ANKLE BRACHIAL INDEX; ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMMON CAROTID ARTERY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DYSLIPIDEMIA; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; OBESITY; OVARY POLYCYSTIC DISEASE; PROTEIN BLOOD LEVEL; PULSE WAVE; SYSTOLIC BLOOD PRESSURE; TESTOSTERONE BLOOD LEVEL;

ADULT; CAROTID ARTERIES; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERTENSION; JAPAN; POLYCYSTIC OVARY SYNDROME; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VASCULAR STIFFNESS;

EID: 79956136300     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2010.01375.x     Document Type: Article

References (45)

1. Franks S. Polycystic ovary syndrome. N Engl J Med 1995; 333: 853-861.
2. Dunaif A. Insulin resistance and the polycystic ovary syn-drome: Mechanism and implications for pathogenesis. Endocr Rev 1997; 18: 774-800. (Pubitemid 28009567)
3. Carmina E, Lobo RA. Polycystic ovary syndrome (PCOS): Arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 1999; 84: 1897-1899. (Pubitemid 30647006)
4. Chekir C, Nakatsuka M, Kamada Y, Noguchi S, Sasaki A, Hiramatsu Y. Impaired uterine perfusion associated with metabolic disorders in women with polycystic ovary syn-drome. Acta Obstet Gynecol Scand 2005; 84: 189-195. (Pubitemid 40278810)
5. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic cri-teria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41-47.
6. Slowinska-Srzednicka J, Zgliczynski S, Wierzbicki M et al. The role of hyperinsulinemia in the development of lipid disturbances in non-obese and obese women with the poly-cystic ovary syndrome. J Endocrinol Invest 1991; 14: 569-575.
7. Legro RS. Polycystic ovary syndrome and cardiovascular disease: A premature association? Endocr Rev 2003; 24: 302-312. (Pubitemid 36724372)
8. Sabuncu T, Vural H, Harma M, Harma M. Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clin Biochem 2001; 34: 407-413. (Pubitemid 32777851)
9. Fenkci V, Fenkci S, Yilmazer M, Serteser M. Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease. Fertil Steril 2003; 80: 123-127. (Pubitemid 36808867)
10. Setji TL, Brown AJ. Polycystic ovary syndrome: Diagnosis and treatment. Am J Med 2007; 120: 128-132. (Pubitemid 46175777)
11. Tasali E, Van Cauter E, Ehrmann DA. Relationships between sleep disordered breathing and glucose metabolism in polycystic ovary syndrome. J Clin Endocrinol Metab 2006; 91: 36-42. (Pubitemid 43069114)
12. Talbott EO, Zborowski JV, Boudreaux MY, McHugh-Pemu KP, Sutton-Tyrrell K, Guzick DS. The relationship between C-reactive protein and carotid intima-media wall thickness in middle-aged women with polycystic ovary syndrome. J Clin Endocrinol Metab 2004; 89: 6061-6067. (Pubitemid 39628415)
13. Xita N, Papassotiriou I, Georgiou I, Vounatsou M, Margeli A, Tsatsoulis A. The adiponectin-to-leptin ratio in women with polycystic ovary syndrome: Relation to insulin resistance and proinflammatory markers. Metabolism 2007; 56: 766-771. (Pubitemid 46734083)
14. Dahlgren E, Janson PO, Johansson S, Lapidus L, Oden A. Polycystic ovary syndrome and risk for myocardial infarction. Acta Obstet Gynecol Scand 1992; 71: 599-603.
15. Birdsall MA, Farquhar CM, White HD. Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization. Ann Intern Med 1997; 126: 32-35. (Pubitemid 27021216)
16. Wild S, Pierpoint T, Jacobs H, McKeigue P. Long-term con-sequences of polycystic ovary syndrome: Results of a 31 year follow-up study. Hum Fertil (Camb) 2000; 3: 101-105.
17. Shaw LJ, Bairey Merz CN, Azziz R et al. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardio-vascular event-free survival: Results from the National Institutes of Health-National Heart, Lung, and Blood Insti-tute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab 2008; 93: 1276-1284. (Pubitemid 351519721)
18. Laurent S, Boutouyrie P, Asmar R et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortal-ity in hypertensive patients. Hypertension 2001; 37:1236-1241. (Pubitemid 34163575)
19. Newman AB, Siscovick DS, Manolio TA et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collabora-tive Research Group. Circulation 1993; 88: 837-845. (Pubitemid 23263998)
20. Covic A, Haydar AA, Bhamra-Ariza P, Gusbeth-Tatomir P, Goldsmith DJ. Aortic pulse wave velocity and arterial wave reflections predict the extent and severity of coronary artery disease in chronic kidney disease patients. J Nephrol 2005; 18: 388-396. (Pubitemid 41700101)
21. Yokoyama H, Shoji T, Kimoto E et al. Pulse wave velocity in lower-limb arteries among diabetic patients with peripheral arterial disease. J Atheroscler Thromb 2003; 10: 253-258.
22. Weber T, Auer J, O'Rourke MF et al. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 2004; 109: 184-189. (Pubitemid 38114137)
23. Emi Y, Adachi M, Sasaki A, Nakamura Y, Nakatsuka M. Increased arterial stiffness in female-to-male transsexuals treated with androgen. J Obstet Gynaecol Res 2008; 34: 890-897.
24. Ferriman D, Gallway JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961; 21:1440-1447.
25. Nakatsuka M, Asagiri K, Noguchi S, Habara T, Kudo T. Nafa-mostat mesilate, a serine protease inhibitor, suppresses lipopolysaccharide-induced nitric oxide synthesis and apop-tosis in cultured human trophoblasts. Life Sci 2000; 67: 1243-1250. (Pubitemid 30620758)
26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resis-tance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419. (Pubitemid 15018832)
27. Yamashina A, Tomiyama H, Takeda K et al. Validity repro-ducibility and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002; 25: 359-364. (Pubitemid 34752554)
28. Sacks D, Bakal CW, Beatty PT et al. Position statement on the use of the ankle-brachial index in the evaluation of patients with peripheral vascular disease: A consensus statement developed by the standards division of the society of cardio-vascular & interventional radiology. J Vasc Interv Radiol 2002; 13: 353. (Pubitemid 34298812)
29. Matsui Y, Kario K, Ishikawa J, Eguchi K, Hoshide S, Shimada K. Reproducibility of arterial stiffness indices (pulse wave velocity and augmentation index) simultaneously assessed by automated pulse wave analysis and their associated risk factors in essential hypertensive patients. Hypertens Res 2004; 27: 851-857. (Pubitemid 40309451)
30. Krentz AJ, von Muhlen D, Barrett-Connor E. Searching for polycystic ovary syndrome in postmenopausal women: Evidence of a dose-effect association with prevalent cardio-vascular disease. Menopause 2007; 14: 284-292. (Pubitemid 46673480)
31. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: A systematic review and meta-analysis. Circulation 2007; 115: 459-467. (Pubitemid 46184197)
32. Takata M, Nakatsuka M, Kudo T. Differential blood flow in uterine, ophthalmic, and brachial arteries of preeclamptic women. Obstet Gynecol 2002; 100: 931-939. (Pubitemid 35387463)
33. Gerhard-Herman M, Gardin JM, Jaff M, Mohler E, Roman M, Naqvi TZ. American Society of Echocardiography; Society for Vascular Medicine and Biology Guidelines for noninva-sive vascular laboratory testing: A report from the American Society of Echocardiography and the Society for Vascular Medicine and Biology. Vasc Med 2006; 11: 183-200. (Pubitemid 46099265)
34. Mather KJ, Verma S, Corenblum B, Anderson TJ. Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome. J Clin Endocrinol Metab 2000; 85: 1851-1856. (Pubitemid 32269288)
35. Bickerton AS, Clark N, Meeking D et al. Cardiovascular risk in women with polycystic ovarian syndrome (PCOS). J Clin Pathol 2005; 58: 151-154. (Pubitemid 40193799)
36. Orio F Jr, Palomba S, Cascella T et al. Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome. J Clin Endocrinol Metab 2004; 89: 4588-4593. (Pubitemid 39244474)
37. Tarkun I, Arslan BC, Canturk Z, Turemen E, Sahin T, Duman C. Endothelial dysfunction in young women with polycystic ovary syndrome: Relationship with insulin resistance and low-grade chronic inflammation. J Clin Endocrinol Metab 2004; 89: 5592-5596. (Pubitemid 39518445)
38. Kravariti M, Naka KK, Kalantaridou SN et al. Predictors of endothelial dysfunction in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005; 90: 5088-5095. (Pubitemid 41262259)
39. Carmina E, Orio F, Palomba Setal. Endothelial dysfunction in PCOS: Role of obesity and adipose hormones. Am J Med 2006; 119: 356. e1-6.
40. Alexandraki K, Protogerou AD, Papaioannou TG et al. Early microvascular and macrovascular dysfunction is not accom-panied by structural arterial injury in polycystic ovary syn-drome. Hormones (Athens) 2006; 5: 126-136.
41. Kelly CJ, Speirs A, Gould GW, Petrie JR, Lyall H, Connell JM. Altered vascular function in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 2002; 87: 742-746. (Pubitemid 34158246)
42. Meyer C, McGrath BP, Teede HJ. Overweight women with polycystic ovary syndrome have evidence of subclinical car-diovascular disease. J Clin Endocrinol Metab 2005; 90: 5711-5716. (Pubitemid 41415480)
43. Vigorito C, Giallauria F, Palomba S et al. Beneficial effects of a three-month structured exercise training program on car-diopulmonary functional capacity in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 2007; 92: 1379-1384. (Pubitemid 46556413)
44. Glueck CJ, Aregawi D, Agloria M, Winiarska M, Sieve L, Wang P. Sustainability of 8% weight loss, reduction of insulin resistance, and amelioration of atherogenic-metabolic risk factors over 4 years by metformin-diet in women with poly-cystic ovary syndrome. Metabolism 2006; 55: 1582-1589. (Pubitemid 44827123)
45. Costello M, Shrestha B, Eden J, Sjoblom P, Johnson N. Insulin-sensitising drugs versus the combined oral contra-ceptive pill for hirsutism, acne and risk of diabetes, cardio-vascular disease, and endometrial cancer in polycystic ovary syndrome. Cochrane Database Syst Rev 2007; (1): CD005552.